Literature DB >> 3953619

Syncope in the elderly.

W Kapoor, D Snustad, J Peterson, H S Wieand, R Cha, M Karpf.   

Abstract

This report describes the evaluation of syncope in 210 elderly patients as compared with 190 younger patients. The elderly group had a mean age of 71 years (range 60 to 90) and the younger group had a mean age of 39 years (range 15 to 59). A cardiovascular cause was found in 33.8 percent of the elderly and in 16.8 percent of the young (p = 0.0001), a noncardiovascular cause in 26.7 percent of the elderly and 37.9 percent of the young (p = 0.02), and unknown cause in 38.5 percent of the elderly and 45.3 percent of the young (NS). Prolonged electrocardiographic monitoring established the diagnosis in 17 percent of the elderly but in only 8 percent of the young (p = 0.008). Syncope resulted in trauma in 39 percent of the elderly and in 32 percent of the young, but the elderly more often had major trauma. The two-year overall mortality was 26.9 +/- 3.4 percent in the elderly and 8.3 +/- 2.1 percent in the young (p less than 0.0001). The overall mortality and incidence of sudden death in the elderly with a cardiovascular diagnosis were similar to those in the young; however, in the elderly with a noncardiovascular diagnosis and syncope of unknown cause, the mortality and incidence of sudden death were higher. Multivariate analyses using mortality and sudden death as endpoints revealed that a cardiovascular cause of syncope was a very strong risk factor. In patients with a noncardiovascular cause or unknown cause of syncope, a history of congestive heart failure, older age, and male sex are important prognostic factors.

Entities:  

Mesh:

Year:  1986        PMID: 3953619     DOI: 10.1016/0002-9343(86)90716-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Increased arterial wave reflection may predispose syncopal attacks.

Authors:  C H Chen; H H Hu; Y P Lin; C M Chern; T L Hsu; P Y Ding
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

2.  Patterns and preexisting risk factors of 30-day mortality after a primary discharge diagnosis of syncope or near syncope.

Authors:  Stephen F Derose; Gelareh Z Gabayan; Vicki Y Chiu; Benjamin C Sun
Journal:  Acad Emerg Med       Date:  2012-05       Impact factor: 3.451

3.  Long-term survival after transient loss of consciousness.

Authors:  R T Lee; E F Cook; S C Day; L Goldman
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

Review 4.  Home Orthostatic Training in Elderly Patients with Vasovagal Syncope - A Prospective Randomised Controlled Trial.

Authors:  Steven Podd; Jacqueline Hunt; Neil Sulke
Journal:  Eur Cardiol       Date:  2015-12

5.  Approach to falls among the elderly in the community.

Authors:  Guat Cheng Ang; Shou Lin Low; Choon How How
Journal:  Singapore Med J       Date:  2020-03       Impact factor: 1.858

Review 6.  The overlap between syncope and falls in the elderly.

Authors:  F E Shaw; R A Kenny
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

Review 7.  Epidemiology of reflex syncope.

Authors:  N Colman; K Nahm; K S Ganzeboom; W K Shen; J Reitsma; M Linzer; W Wieling; H Kaufmann
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

8.  Causes of syncope in patients with Alzheimer's disease treated with donepezil.

Authors:  Philippe Bordier; Stephane Lanusse; Stephane Garrigue; Charlotte Reynard; Frederic Robert; Laurent Gencel; Alexia Lafitte
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 9.  Non-invasive management of vasovagal syncope.

Authors:  Samuel T Coffin; Satish R Raj
Journal:  Auton Neurosci       Date:  2014-06-21       Impact factor: 3.145

10.  Predictors of 30-day serious events in older patients with syncope.

Authors:  Benjamin C Sun; Stephen F Derose; Li-Jung Liang; Gelareh Z Gabayan; Jerome R Hoffman; Alison A Moore; William R Mower; Carol M Mangione
Journal:  Ann Emerg Med       Date:  2009-09-19       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.